114 related articles for article (PubMed ID: 31465770)
1. Genistein upregulates cyclin D1 and CDK4 expression and promotes the proliferation of ovarian cancer OVCAR-5 cells.
Wang Y; Li W; Wang Z; Ren H; Li Y; Zhang Y; Yang P; Pan S
Clin Chim Acta; 2021 Jan; 512():100-105. PubMed ID: 31465770
[TBL] [Abstract][Full Text] [Related]
2. Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression.
Hwang KA; Kang NH; Yi BR; Lee HR; Park MA; Choi KC
Int J Oncol; 2013 Feb; 42(2):733-40. PubMed ID: 23229410
[TBL] [Abstract][Full Text] [Related]
3. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
Li Y; Mi C
Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
[TBL] [Abstract][Full Text] [Related]
4. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
[TBL] [Abstract][Full Text] [Related]
5. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.
Yan H; Tong J; Lin X; Han Q; Huang H
Mol Med Rep; 2015 Aug; 12(2):1783-8. PubMed ID: 25891642
[TBL] [Abstract][Full Text] [Related]
6. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
7. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
8. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.
Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H
J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.
Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E
Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422
[TBL] [Abstract][Full Text] [Related]
10. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
11. 15-Hydroxy-8(17),13(E)-labdadiene-19-carboxylic acid (HLCA) inhibits proliferation and induces cell cycle arrest and apoptosis in ovarian cancer cells.
Bakhtiari H; Gheysarzadeh A; Ghanadian M; Aghaei M
Life Sci; 2021 Feb; 267():118981. PubMed ID: 33385409
[TBL] [Abstract][Full Text] [Related]
12. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
Gao M; Ma Y; Bast RC; Li Y; Wan L; Liu Y; Sun Y; Fang Z; Zhang L; Wang X; Wei Z
Med Oncol; 2016 Jul; 33(7):73. PubMed ID: 27277757
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation and induction of G1-phase cell-cycle arrest by dFMGEN, a novel genistein derivative, in lung carcinoma A549 cells.
Peng B; Cao J; Yi S; Wang C; Zheng G; He Z
Drug Chem Toxicol; 2013 Apr; 36(2):196-204. PubMed ID: 22931124
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
15. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
[TBL] [Abstract][Full Text] [Related]
16. Blocking effects of genistein on cell proliferation and possible mechanism in human gastric carcinoma.
Cui HB; Na XL; Song DF; Liu Y
World J Gastroenterol; 2005 Jan; 11(1):69-72. PubMed ID: 15609399
[TBL] [Abstract][Full Text] [Related]
17. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L
Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945
[TBL] [Abstract][Full Text] [Related]
18. Targeting cleavage and polyadenylation specific factor 1 via shRNA inhibits cell proliferation in human ovarian cancer.
Zhang B; Liu Y; Liu D; Yang L
J Biosci; 2017 Sep; 42(3):417-425. PubMed ID: 29358555
[TBL] [Abstract][Full Text] [Related]
19. Modulation of microRNA associated with ovarian cancer cells by genistein.
Parker LP; Taylor DD; Kesterson J; Metzinger DS; Gercel-Taylor C
Eur J Gynaecol Oncol; 2009; 30(6):616-21. PubMed ID: 20099489
[TBL] [Abstract][Full Text] [Related]
20. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
Chen X; Anderson JJ
Nutr Cancer; 2001; 41(1-2):165-71. PubMed ID: 12094620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
